Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05547698

A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation

The purpose of this research study is to compare the technique of performing bilateral lung transplantation off-pump vs venoarterial ECMO (VA ECMO). The goal of the trial is to determine which technique has lower rates of primary graft dysfunction.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University Of Louisville, Louisville, Kentucky, United States

Loading trial locations.

About this study

The Investigators of the Extracorporeal Life Support Registry in Lung Transplantation (ECLS Registry) has studied the impact of the type of intraoperative extracorporeal life support on primary graft dysfunction (PGD) after lung transplantation (LTx) in an international registry. The investigators have demonstrated that severe PGD at 48-72 hours is greater when LTx is performed using cardiopulmonary bypass (CPB) (43%) when compared to veno-arterial (VA) ECMO. However, PGD after VA ECMO remained high (29%) when compared to off-pump (12%). Conversely, there are retrospective series showing that when compared to off-pump technique, VA ECMO has reduced PGD rates and improved survival. Because selection bias and unknown confounders in retrospective studies could have been the cause of these conflicting results, part of the ECLS Registry Investigators are committed to a prospective multicenter randomized trial comparing off-pump versus VA ECMO LTx.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Bilateral Lung Transplantation (LTx) recipients.
  • Mean pulmonary artery pressure < or = 35 mmHg.
  • Eligible for off-pump or VA ECMO based on the judgement of the attending surgeon.

Exclusion criteria

  • Single lung transplant
  • Multiorgan transplant.
  • Donor after cardiac death (DCD).
  • Re-transplant.
  • Intention to use prophylactic post-operative ECMO.
  • Previous major lung surgery. Video-assisted thoracoscopic surgery (VATS) and wedge resection are not an exclusion criterion.
  • Previous pleurodesis.
  • Preoperative ECMO and/or mechanical ventilation.

Treatment and study plan

Off-pump lung transplantation

Procedure

General anesthesia, intubation with double lumen tube, thoracotomies or clamshell incision, pneumonectomy starting by the less perfused lung in the scan, stump preparation, lung implantation, reperfusion, gradual release of the pulmonary artery clamp, deairing, ventilation of the 1st implanted lung. The process is repeated at the contralateral side. Ventilation of both lungs, chest closure.

Venoarterial ECMO lung transplantation

Procedure

General anesthesia, intubation with double lumen tube, thoracotomies or clamshell incision, heparin, peripheral or central venoarterial ECMO cannulation, first pneumonectomy, stump preparation, lung implantation, reperfusion, release of the pulmonary artery clamp, deairing, ventilation of the 1st implanted lung. The process is repeated at the contralateral side. Ventilation of both lungs, ECMO decannulation, chest closure.

Primary outcomes

  1. Primary Lung Graft Dysfunction (PGD) grade 3

    Time frame: 48-72 hours

    Rate of PGD according to the The International Society for Heart and Lung Transplantation (ISHLT) classification

  2. Mortality

    Time frame: 90 days

    Death rate of subjects following lung transplantation

  3. Primary Lung Graft Dysfunction (PGD) grade 3 and Mortality

    Time frame: 48-72 hours and 90 days

    Rate of PGD according to the The International Society for Heart and Lung Transplantation (ISHLT) classification plus the Death rate of subjects following lung transplantation

Secondary outcomes

  1. Red blood cell transfusions

    Time frame: Intraoperative plus the first 24 hours in the ICU

    Number of subjects to require red blood cell transfusions

  2. Chest tube output

    Time frame: First 24 hours

    Chest tube output the first 24 hours following lung transplantation reported in cubic centimeter (cc)

  3. Incidence of re-exploration for bleeding

    Time frame: First 48 hours

    Number of subject to require re-exploration for bleeding

  4. Incidence of air emboli

    Time frame: During VA ECMO run

    Number of subjects to experience air emboli

  5. Incidence of stroke

    Time frame: 90 days or discharge from the index hospitalization

    Number of subjects to experience stroke

  6. Incidence of Primary Lung Graft Dysfunction (PGD) grade 3

    Time frame: At 0 hours (ICU arrival) and 24 hours

    Number of subjects to experience a PGD grade 3 following lung transplantation. PGD will be rated according to the The International Society for Heart and Lung Transplantation (ISHLT) classification

  7. Incidence of pneumonia

    Time frame: 90 days or discharge from the index hospitalization

    Number of subjects to experience pneumonia

  8. Incidence of need for dialysis

    Time frame: 90 days or discharge from the index hospitalization

    Number of subjects to need dialysis

  9. Incidence of transplant rejection

    Time frame: 90 days or discharge from the index hospitalization

    Number of subjects to experience transplant rejection

  10. Incidence of bronchial dehiscence

    Time frame: 90 days or discharge from the index hospitalization

    Number of subjects to experience bronchial dehiscence

  11. Incidence of tracheostomy

    Time frame: 90 days or discharge from the index hospitalization

    Number of subjects to require tracheostomy

  12. Length of mechanical ventilation

    Time frame: 90 days or discharge from the index hospitalization

    Total amount of time subjects require mechanical ventilation following lung transplantation

  13. Length of stay

    Time frame: 90 days or discharge from the index hospitalization

    Total amount of time subjects are hospitalized

Study contacts

Contact information is provided by the study sponsor or research team.

Jackie Reiter

CONTACT

[email protected]

507-538-2224

Mauricio Villavicencio, MD, MBA

CONTACT

[email protected]

507-2557068

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Registry information

Official study title

Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation VIP BOLT Trial: A Multicenter Prospective Randomized Trial

Important dates

Study start
2022
Primary completion
2026
Study completion
2027
First posted
Sep 21, 2022
Registry last updated
May 1, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.